Felix Llanos Tejada

Felix Llanos Tejada

Auto-generated profile, based on publicly available information

Felix Llanos Tejada

Universidad Ricardo Palma

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 June 2018 in Chest
Verified
Journal Article
Open access
APAlvaro Proaño
Alvaro Proaño
DBDavid Pham Bui
David Pham Bui
Jose W LopezJose W Lopez
Jose W Lopez
NVNancy M. Vu
Nancy M. Vu
MBMarjory A. Bravard
Marjory A. Bravard
EOEyal Oren
Eyal Oren
Cough frequency, and its duration, is a biomarker that can be used in low-resource settings without the need of laboratory culture and has been associated with transmission and treatment response. Radiologic characteristics associated with increased cough frequency may be important in understanding transmission. The relationship between cough frequency and cavitary lung disease has not been studied. We analyzed data in 41 adults who were HIV negative and had culture-confirmed, drug-susceptible pulmonary TB throughout treatment. Cough recordings were based on the Cayetano Cough Monitor, and sputum samples were evaluated using microscopic observation drug susceptibility broth culture; among culture-positive samples, bacillary burden was assessed by means of time to positivity. CT scans were analyzed by a US-board-certified radiologist and a computer-automated algorithm. The algorithm evaluated cavity volume and cavitary proximity to the airway. CT scans were obtained within 1 month of treatment initiation. We compared small cavities (≤ 7 mL) and large cavities (> 7 mL) and cavities located closer to (≤ 10 mm) and farther from (> 10 mm) the airway to cough frequency and cough cessation until treatment day 60. Cough frequency during treatment was twofold higher in participants with large cavity volumes (rate ratio [RR], 1.98; P = .01) and cavities located closer to the airway (RR, 2.44; P = .001). Comparably, cough ceased three times faster in participants with smaller cavities (adjusted hazard ratio [HR], 2.89; P = .06) and those farther from the airway (adjusted HR, 3.61;, P = .02). Similar results were found for bacillary burden and culture conversion during treatment. Cough frequency during treatment is greater and lasts longer in patients with larger cavities, especially those closer to the airway.

11 September 2020 in Revista de la Facultad de Medicina Humana
Verified
Journal Article
Open access
PDF file
KPKenneth G. Vargas Ponce
Kenneth G. Vargas Ponce
ALAntonio Salas López
Antonio Salas López
FTFelix Llanos Tejada
Felix Llanos Tejada
AAAntonio Morales Avalos
Antonio Morales Avalos
La enfermedad de COVID-19 es una infección de fácil transmisión al igual que otros virus respiratorios, reportándose casos de coinfección de Influenza en épocas estacionales. Se presentan 5 casos de coinfección de COVID-19 y el virus de la Influenza siendo el más frecuente el virus de la Influenza A, los síntomas odinofagia y congestión nasal pueden hacer pensar en coinfección existente entre estos dos virus, esta coinfección no se relacionan con peor pronóstico ni mortalidad aparentemente.

1 July 2021 in Horizonte Médico (Lima)
Verified
Journal Article
Open access
PDF file
PLPerú. Universidad de San Martín de Porres Hospital Nacional Dos de Mayo. Lima
Perú. Universidad de San Martín de Porres Hospital Nacional Dos de Mayo. Lima
FTFélix K. Llanos Tejada
Félix K. Llanos Tejada
WTWendy I. Muñoz Taipe
Wendy I. Muñoz Taipe
FPFacultad de Medicina Humana. Lima Universidad de San Martín de Porres
Facultad de Medicina Humana. Lima Universidad de San Martín de Porres
NANataly L. Muñoz Abanto
Nataly L. Muñoz Abanto
JLJ. Antonio Salas Lopez
J. Antonio Salas Lopez
La infección por COVID-19 presenta una elevada mortalidad respecto a otros virus respiratorios. En este artículo buscamos definir las comorbilidades que están asociadas a la elevada mortalidad o a las complicaciones que requieren mayor soporte ventilatorio en unidades de cuidados intensivos. Se ha diseñado una búsqueda bibliográfica con respecto a las comorbilidades y/o alteraciones en los exámenes de laboratorio y los estudios radiológicos que se han asociado a la presencia de mortalidad, especialmente en los casos descritos en China. SUMMARY COVID-19 infection has high mortality compared to other respiratory viruses. In this article, we seek to define comorbid conditions that are associated with high mortality or complications that require ventilatory support in Intensive Care Units. A bibliographic search has been designed with respect to those comorbidities and/or alterations in laboratory tests that have been associated with the presence of mortality, especially those described in China.

24 August 2025 in Respiratory Medicine and Research
Verified
Journal Article
Open access
VVVictor Juan Vera-Ponce
Victor Juan Vera-Ponce
JCJhosmer Jhonatan Ballena Caicedo
Jhosmer Jhonatan Ballena Caicedo
JRJUAN CARLOS BUSTAMANTE RODRIGUEZ
JUAN CARLOS BUSTAMANTE RODRIGUEZ
FZFiorella E. Zuzunaga-Montoya
Fiorella E. Zuzunaga-Montoya
LVLuisa Erika Milagros Vásquez-Romero
Luisa Erika Milagros Vásquez-Romero
FTFelix Llanos Tejada
Felix Llanos Tejada
Although chest radiography (CXR) has traditionally been used as the initial diagnostic test, pulmonary ultrasound (US) has emerged in recent years as a radiation-free, portable, and potentially more sensitive and specific alternative. To evaluate the diagnostic accuracy of US compared to CXR for detecting community-acquired pneumonia (CAP) in adults through a systematic review and meta-analysis. Comprehensive searches were conducted in SCOPUS, Web of Science, PubMed, and EMBASE databases. Observational studies comparing US with CXR in diagnosing CAP were included, using computed tomography as the reference standard for all patients. Random-effect models were used for statistical analysis, calculating sensitivity, specificity, likelihood ratios (LR), and diagnostic odds ratios (DOR). Meta-regression analyses were performed, and SROC curves were constructed to compare diagnostic performance. Eight studies using CT as a reference standard were included. US showed superior performance with sensitivity 90.0 % (95 % CI: 81.3-96.2 %), specificity 90.8 % (95 % CI: 79.9-97.7 %), LR+ 9.45 (95 % CI: 3.73-23.94), LR- 0.12 (95 % CI: 0.06-0.24), and DOR 79.74. CXR demonstrated lower values with sensitivity 72.6 % (95 % CI: 61.7-82.4 %), specificity 82.0 % (95 % CI: 65.5-93.9 %), LR+ 3.98 (95 % CI: 1.87-8.49), LR- 0.36 (95 % CI: 0.23-0.54), and DOR 11.17. Both modalities showed significant heterogeneity, which was not explained by the sample size in meta-regression. Pulmonary US demonstrates substantially higher diagnostic accuracy than CXR for CAP detection, with particularly strong performance in excluding pneumonia as evidenced by its low negative LR. While CXR maintains relevance where US is unavailable or for evaluating specific thoracic conditions, implementing US can optimize pneumonia diagnosis and potentially reduce unnecessary antibiotic use, particularly in emergency and critical care settings.

21 November 2020 in Revista de Gastroenterología del Perú
Verified
Journal Article
Closed access
GCGloria Vargas Cárdenas
Gloria Vargas Cárdenas
LYLucía Balvin Yanes
Lucía Balvin Yanes
JMJimena Marisol Chaiña Meza
Jimena Marisol Chaiña Meza
FTFélix Llanos Tejada
Félix Llanos Tejada
Objetivo: Determinar los factores asociados a la adherencia al tratamiento de erradicación de Helicobacter pylori en pacientescon la infección. Materiales y métodos: Se realizó un estudio observacional analítico de cohorte prospectivo longitudinaldonde se incluyó a 100 pacientes que iniciaron el tratamiento de erradicación de Helicobacter pylori. Se aplicó el test de Morisky Green para medir la adherencia al tratamiento y el test de Batalla para medir el conocimiento sobre la infección de Helicobacter pylori. Se realizó la prueba Chi cuadrado para determinar la asociación de los factores con la adherencia al tratamiento y el análisis de regresión logística para estimar RR crudo y RR ajustado. Resultados: De los 100 pacientes, seencontró que el 64% fueron mujeres. El promedio de edad fue de 49,9 años y el 65% fue adherente al tratamiento. Los factores asociados a falta de adherencia al tratamiento fueron: edad menor de 50 años (RR ajustado: 3,95, IC 95%: 1,09-14,33), falta de estudios superiores (RR ajustado: 5,1, IC 95%: 1,26-20,5) y presencia de reacciones adversas (RR ajustado: 5,88, IC 95%: 1,56-22,2). Conclusiones: La mayoría de los pacientes resultaron adherentes al tratamiento. Los factores de riesgo para mala adherencia fueron la presencia de reacciones adversas, edad menor de 50 años y la falta de estudios superiores.

18 June 2021 in Revista de la Facultad de Medicina Humana
Verified
Journal Article
Open access
PDF file
ÍRÍtalo Renato Valero Román
Ítalo Renato Valero Román
FLFélix Llanos-Tejada
Félix Llanos-Tejada
Introduction: The overused of antibiotics has existed as a threat to public health for several years. The World Health Organization (WHO) warns that in the year 2050 the "post-antibiotic era" will begin, where approximately 10 million deaths per year will be attributed to resistant infections. The infection where this type of bacteria is most relevant is in urinary tract pathology. Objective: Determine the factors associated with the development of urinary tract infections by beta-lactamase-producing bacteria in older adults in the internal medicine service of the Dos de Mayo National Hospital. Methods: An analytical, cross-sectional, retrospective, case-control type study was carried out. Data were obtained through the review of medical records, with the completion of a data collection form related to sociodemographic aspects such as clinical data. With a total sample of 139 patients, 56 cases and 86 controls were obtained. To measure the association, we used the Odds Ratio, the statistical software SPSS was used. Results: A statistically significant association was observed between E. Coli ESBL infection with antecedents such as previous use of antibiotics and a history of recurrent urinary infection. The ORs and the confidence intervals of the variables that were shown to be significant were: recurrent urinary tract infection (95% CI, OR = 1,722), Anemia (95% CI OR = 1.96), Hypothyroidism (95% CI, OR = 1.13), Hypertension (95% CI, OR = 1,050), multi-pregnancy (95% CI, OR = 1,062) and History of previous antibiotic use (95% CI, OR = 22,106). Conclusion: The study identified the average age of presentation of urinary infection by E. Coli ESBL is between 65 to 75 years. Recurrent urinary tract infections and previous use of antibiotic treatment are significant risk factors for developing ESBL bacterial infections.